GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a significant focus in therapeutic research, largely due to its remarkable impact on managing ailments such as second type diabetes and weight gain. New studies have shown that beyond glucose regulation, GLP-1 agonists offer promise for heart health and possibly neurode